Skip to content
Shuttingdown

Lantern Pharma Inc.

Pharmaceutical Preparations · DALLAS · TX

Distress signal

Moderate confidence (50%)

Updated Oct 20, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Lantern Pharma Inc. received a delisting notice from its exchange (Sep 25, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Lantern Pharma Inc. received a delisting notice from its exchange

    Sep 25, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 25, 2026, Lantern Pharma Inc. (the Company ) received notice (the Notice ) from The Nasdaq Stock Market LLC ( Nasdaq ) that the Company is not in compliance with Nasdaq s Listing Rule 5550(b)(2), as the market value of listed securities (the MVLS Requirement ) for the Company s common stock had been below the minimum MVLS Requirement of $35,000,000 for the last 30 consecutive business days. Nasdaq also noted that the Company does not meet the requirements under Listing Ru…”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
Listing
SEC lists the ticker LTRN on Nasdaq.
SEC CIK
0001763950
Website
—
LinkedIn
—
Headquarters
DALLAS, TX
Also known as
Lantern Pharma
Legal entities
Lantern Pharma Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Lantern Pharma Inc. — Pharmaceutical Preparations (SIC 2834) — DALLAS, TX
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 25, 2026, Lantern Pharma Inc. (the Company ) received notice (the Notice ) from The Nasdaq Stock Market LLC ( Nasdaq ) that the Company is not in compliance with Nasdaq s Listing Rule 5550(b)(2), as the market value of listed securities (the MVLS Requirement ) for the Company s common stock had been below the minimum MVLS Requirement of $35,000,000 for the last 30 consecutive business days. Nasdaq also noted that the Company does not meet the requirements under Listing Ru…
    View source record

Status history

Every derived status, with the rule that produced it.

  • UNKNOWN → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Oct 4, 2026, 12:07 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.